Department of Health Policy
-
October 26, 2017
Edwards, Schaffner honored by major infectious diseases organizations
Two highly regarded Vanderbilt University Medical Center (VUMC) infectious disease clinicians were recognized with service awards from prominent organizations during IDWeek in San Diego, California, Oct. 4-8. -
October 12, 2017
VIGH receives federal grants to fight kidney disease
Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria. -
August 3, 2017
Researchers study unique couples intervention in Mozambique to reduce HIV transmission
Researchers in the Vanderbilt Institute for Global Health are testing whether a unique “couples-centered” intervention developed in the southern African nation of Mozambique can reduce mother-to-child transmission of HIV. -
June 15, 2017
Patrick honored for neonatal abstinence syndrome research
Stephen W. Patrick, M.D., MPH, MS, has been chosen to receive the Nemours Child Health Services Research Award, recognizing his work surrounding neonatal abstinence syndrome, a drug withdrawal syndrome experienced by infants exposed to opioids while in utero. -
June 15, 2017
Schaffner receives UpShot Award in vaccine communication
The National Vaccine Program Office in the U.S. Department of Health and Human Services has selected William Schaffner, M.D., to receive its 2017 NVPO UpShot Award in Vaccine Communication. -
May 11, 2017
Hepatitis C infections among pregnant women increasing
Hepatitis C infections among pregnant women nearly doubled from 2009-2014, likely a consequence of the country’s increasing opioid epidemic that is disproportionately affecting rural areas of states including Tennessee and West Virginia. -
May 4, 2017
Study finds male infants at increased risk for NAS
Male infants are more likely at birth than their female counterparts to be diagnosed with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), and to require treatment, according to a new Vanderbilt study published in Hospital Pediatrics.